# History and Physical

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Ernest Shackleton (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-EX001-SYN
- Date: 2026-05-12
- Fictional facility: St. Posthumous Health Center
- Fictional author: Cormac Ellingsworth-Daly, MD
- Calendar frame: modern shifted

## Reason for visit

New patient visit for chest tightness and breathlessness on exertion in a heavy smoker planning a polar expedition: risk assessment, ECG and blood tests, starting treatment, smoking and alcohol counseling, and a cardiology referral. **S**

## Historical basis

- Ernest Henry Shackleton was born on February 15, 1874, at Kilkea, County Kildare, Ireland, the son of Dr. Henry Shackleton, of a well-known Quaker family. **D**
- On the southern sledge journey of the Discovery expedition he became unable to pull the sledge because of breathlessness and weakness; the collapse was attributed to scurvy and "a sort of asthma," and he was invalided home against his will in 1903. **D**
- On the Nimrod expedition (1907 to 1909), its medical officer Eric Marshall recorded in his diary on January 20, 1908, that Shackleton was very unwell after pulling on a rope, and twice heard a pulmonary systolic murmur. **D**
- On the Imperial Trans-Antarctic (Endurance) expedition of 1914 to 1917, of fifty-six men three died in the Antarctic: Mackintosh, Hayward, and Spencer-Smith of the Ross Sea party. No member of the Endurance's own party died. **D**
- His colleague Dr. James McIlroy later recalled that on one occasion Shackleton would not undress and let him listen to his heart. **D**
- He was a heavy cigarette smoker for most of his life. **D**
- After the war he returned to London. In 1921, with John Quiller Rowett taking on practically the whole financial responsibility, he turned his planned Arctic expedition into the Shackleton-Rowett expedition to the South; it was organized and equipped within three months, its sailing was postponed beyond August 20 by a strike of ships' joiners and other delays, and the Quest left St. Katharine's Dock in London on September 17, 1921. **D**

5 later historical claims are omitted because they describe events after the index age. See the teaching note.

These claims are historical evidence, not findings from a real modern examination.

## History of present illness

This fictional modern episode addresses the presenting concerns below. **S**

- He is afraid a heart diagnosis will stop the expedition he has promised to lead. **S**
- He will be weeks from a hospital at sea and in the far south. **S**

## Strengths and supports

- Engagement in care and meaningful activity **S**

## Medications and allergies

- Aspirin 81 mg delayed-release tablet, one tablet by mouth daily **S**
- Atorvastatin 80 mg tablet, one tablet by mouth daily **S**
- Metoprolol succinate extended-release 50 mg tablet, one tablet by mouth daily **S**
- Nitroglycerin 0.4 mg sublingual tablet, one tablet under the tongue for chest pain, repeat every 5 minutes up to 3 doses **S**
- Varenicline 1 mg tablet, one tablet by mouth twice a day after a one-week starter titration **S**
- No known allergy **S**

## Past medical history

True biography with historical dates; these events are not part of the synthetic care timeline.

- 1903: Breathlessness and weakness that stopped him pulling a sledge on a polar journey in his late twenties, attributed at the time to scurvy and asthma; sent home **D** (CLM-0002)
- January 20, 1908: Very unwell after heavy hauling on a rope on a polar expedition in his thirties; a pulmonary systolic murmur heard twice by the expedition doctor **D** (CLM-0003)

## Procedures and immunizations

- 2026-05-12 to 2026-05-12: Resting twelve-lead electrocardiogram **S**


## Family history

- No family medical history is documented in the logged sources. Family history of real relatives is never synthesized.

## Measurements

Total cholesterol: 246 mg/dL (high); HDL cholesterol: 38 mg/dL (low); LDL cholesterol: 168 mg/dL (high); Triglycerides: 200 mg/dL (high); HbA1c: 5.9% (high); Potassium: 4.4 mmol/L; Creatinine: 0.98 mg/dL; ALT: 41 U/L; Hemoglobin: 15.8 g/dL; TSH: 1.9 mIU/L; eGFR: 96 mL/min/1.73 m²; PHQ-2: 1; AUDIT: 12. All results are synthetic.

BP 138/86 mmHg; pulse 78 bpm; respirations 16/min; temperature 36.7 °C; oxygen saturation 97% on room air; weight 86 kg; BMI 28.1 kg/m². All vital signs are synthetic.

## Examination

Mental status: Alert, warm, and forceful; optimistic and impatient with delay; PHQ-2 score 1. Functional status: Independent; stops on the second flight of stairs or after carrying a crate a short distance until the tightness passes. Physical examination is intentionally limited. **S**

## Assessment

1. Chest tightness and breathlessness on exertion for about three months, brought on by stairs, carrying loads, and walking fast in cold wind and relieved within minutes by rest, never at rest; resting ECG normal; cause not yet established at intake; coronary CT angiography and cardiology consultation requested; status draft. **S**
2. Nicotine dependence, cigarettes: about 25 a day since 16 (about 39 pack-years); status draft. **S**
3. Hyperlipidemia: LDL cholesterol 168 mg/dL and HDL 38 mg/dL at intake; status draft. **S**
4. Prediabetes: HbA1c 5.9% at intake; status draft. **S**

## Plan

- Cardiology consultation in two weeks with coronary CT angiography for suspected stable angina, and advice on revascularization and on fitness for the expedition. Guideline: 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease (Virani SS, et al. Circulation 2023;148(9):e9-e119) (2023); 2024 ESC Guidelines for the management of chronic coronary syndromes (Vrints C, et al. Eur Heart J 2024;45(36):3415-3537) (2024) **S**
- Medical therapy from intake for suspected angina: aspirin 81 mg, atorvastatin 80 mg, metoprolol succinate, and sublingual nitroglycerin with written instructions to call emergency services if pain lasts more than 5 minutes after the first dose. Guideline: 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease (Virani SS, et al. Circulation 2023;148(9):e9-e119) (2023); 2024 ESC Guidelines for the management of chronic coronary syndromes (Vrints C, et al. Eur Heart J 2024;45(36):3415-3537) (2024); CMID: Clinical Monitoring Intelligence Database, ischemic heart disease and hyperlipidemia monographs (2026) **S**
- Stop smoking: varenicline for 12 weeks, with the option of 12 more, a quit date in one week, counseling at each visit, and the quitline. Guideline: 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease (Virani SS, et al. Circulation 2023;148(9):e9-e119) (2023); Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions (2021) **S**
- AUDIT with a brief intervention for hazardous drinking: no more than two drinks a day and several alcohol-free days a week, with AUDIT-C at follow-up. Guideline: 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease (Virani SS, et al. Circulation 2023;148(9):e9-e119) (2023); Unhealthy Alcohol Use in Adolescents and Adults: Screening and Behavioral Counseling Interventions (2018) **S**
- Prediabetes: diet and activity counseling and HbA1c in about four months. Guideline: 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease (Virani SS, et al. Circulation 2023;148(9):e9-e119) (2023); Prediabetes and Type 2 Diabetes: Screening (2021) **S**

## Guideline basis

- 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease (Virani SS, et al. Circulation 2023;148(9):e9-e119) (2023), American Heart Association and American College of Cardiology
- 2024 ESC Guidelines for the management of chronic coronary syndromes (Vrints C, et al. Eur Heart J 2024;45(36):3415-3537) (2024), European Society of Cardiology
- CMID: Clinical Monitoring Intelligence Database, ischemic heart disease and hyperlipidemia monographs (2026), Aether Forge
- Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions (2021), U.S. Preventive Services Task Force
- Unhealthy Alcohol Use in Adolescents and Adults: Screening and Behavioral Counseling Interventions (2018), U.S. Preventive Services Task Force
- Prediabetes and Type 2 Diabetes: Screening (2021), U.S. Preventive Services Task Force
